Drugs / SPV-T3a-RTA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02027805 | Mar 2014 → Sep 2016 | graft versus host disease | Xenikos | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SPV-T3a-RTA | “Combination of SPV-T3a-RTA and WT1-RTA (equal parts, w/w)” NCT02027805 ↗ |